Labcorp Holdings recently reported better-than-expected Q3 2025 adjusted EPS of $4.18 but cut its contract research unit’s annual and full-year revenue growth forecasts due to a prolonged funding ...

Cofactor Genomics, a commercial-stage diagnostics company transforming precision oncology through RNA-based predictive tests, today announced strategic investments from Labcorp and Ascension Ventures.

Labcorp's strategic partnerships, specialty test growth and more attractive valuation tilt the balance as it emerges stronger than Hologic right now.

Community Health Systems on Tuesday sold some of its ambulatory outpatient laboratory services to Labcorp for approximately $194 million in cash before transaction expenses. The deal includes assets ...

A nurse-led intervention addressed completion of preinfusion lab tests, improving patient preparedness for infusion, multidisciplinary coordination, and patient outcomes.

Detailed price information for Laboratory Corp of America Holdings (LH-N) from The Globe and Mail including charting and trades.

Valued at a market cap of $21.9 billion, Labcorp Holdings Inc. (LH) is a leading provider of comprehensive laboratory services. The company operates through its Diagnostics Laboratories and Biopharma ...

Siemens Healthineers has tapped the Alzheimer’s disease blood test developer ALZpath for an in vitro diagnostic to ...

The 5 testing & diagnostics services stocks we track reported a very strong Q3. As a group, revenues beat analysts’ consensus ...

The eight largest publicly traded companies headquartered in the Triangle range from clinical research giants and a ...

The company says it can turn profits without its customers facing the usual out-of-pocket costs or high premiums. Economists ...

During the year, the industry saw continued consolidation, the end of a key advisory body, the rise in DTC testing and advanced diagnostics, and another stab at PAMA reform.